Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada-Reference-Cited by-同舟云学术

Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada

Published:2019-12-01 Issue:10 Volume:29 Page:730-739
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Lachaine Jean¹,Ben Amor Leila²,Pringsheim Tamara³⁴⁵⁶,Burns James⁷,van Stralen Judy⁸⁹

Affiliation:

1. Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada.

2. Department of Psychiatry, University of Montreal, Montreal, Quebec, Canada.

3. Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

4. Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.

5. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

6. Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.

7. Shire, a Takeda company, Toronto, Ontario, Canada.

8. Center for Pediatric Excellence, Ottawa, Ontario, Canada.

9. Department of Paediatrics, Queen's University, Ottawa, Ontario, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2019.0097

Reference29 articles.

1. Risperidone Effects in the Presence/Absence of Psychostimulant Medicine in Children with ADHD, Other Disruptive Behavior Disorders, and Subaverage IQ

2. Risperidone Augmentation for Treatment-Resistant Aggression in Attention-Deficit/Hyperactivity Disorder

3. Methyiphenidate vs. amphetamine: Comparative review

4. Antipsychotics in pediatric and adolescent patients: A review of comparative safety data

5. Index